Crocs - CROX Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Crocs in the last twelve months. There are currently 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CROX shares.
View CROX analyst ratings or view top-rated stocks.

8 Wall Street analysts have issued 1-year price objectives for Crocs' stock. Their CROX share price forecasts range from $54.00 to $165.00. On average, they predict the company's stock price to reach $121.29 in the next twelve months. This suggests a possible upside of 3.9% from the stock's current price.
View analysts price targets for CROX or view top-rated stocks among Wall Street analysts.

Crocs' stock was trading at $108.43 on January 1st, 2023. Since then, CROX shares have increased by 7.7% and is now trading at $116.78.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our CROX earnings forecast.

Crocs will be holding an earnings conference call on Thursday, February 16th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Crocs, Inc. (NASDAQ:CROX) released its quarterly earnings data on Wednesday, October, 20th. The textile maker reported $2.47 earnings per share for the quarter, topping analysts' consensus estimates of $1.88 by $0.59. The textile maker had revenue of $625.92 million for the quarter, compared to the consensus estimate of $609.75 million. Crocs had a net margin of 17.43% and a trailing twelve-month return on equity of 172.58%. The company's revenue was up 73.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.94 EPS.

Crocs updated its fourth quarter 2022 earnings guidance on Tuesday, January, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $938.60 million-$938.60 million, compared to the consensus revenue estimate of $900.09 million.

67 employees have rated Crocs Chief Executive Officer Andrew Rees on Glassdoor.com. Andrew Rees has an approval rating of 83% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Crocs investors own include Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Bank of America (BAC), Denbury Resources (DNR), Cisco Systems (CSCO), Micron Technology (MU), AT&T (T) and Tesla (TSLA).

Crocs trades on the NASDAQ under the ticker symbol "CROX."

Crocs' stock is owned by many different retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.93%), Simplex Trading LLC (0.00%), New York State Common Retirement Fund (0.38%), Empire Life Investments Inc. (0.25%), Lisanti Capital Growth LLC (0.22%) and TLW Wealth Management LLC (0.22%). Insiders that own company stock include Andrew Rees, Anne Mehlman, Beth J Kaplan, Daniel P Hart, Doreen A Wright, Douglas J Treff, Elaine L Boltz, Ian Bickley, Michelle Poole, Ronald Frasch, Shannon Sisler and Thomas J Smach.
View institutional ownership trends.

Shares of CROX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CROX stock can currently be purchased for approximately $116.78.

Crocs (NASDAQ:CROX) has a market capitalization of $7.21 billion and generates $2.31 billion in revenue each year. The textile maker earns $725.69 million in net income (profit) each year or $9.06 on an earnings per share basis.

The company employs 5,770 workers across the globe.

Crocs' mailing address is 13601 Via Varra, Broomfield CO, 80020. The official website for the company is www.crocs.com. The textile maker can be reached via phone at (303) 848-7000, via email at brendon.frey@icrinc.com, or via fax at 303-468-4266.